Dysregulated myelopoiesis is identified as a driver of nutritionally acquired immunodeficiency that persists after refeeding and nutritional recovery, indicating exposure to food scarcity may be an ...

Clonal hematopoiesis is common and associated with adverse outcomes, particularly in patients with cancer. Although conventional cytotoxic therapies are known to drive clonal hematopoiesis, ...

The research looked specifically at blood stem cells, which live in the bone marrow and make different types of blood cells.

Scientists discovered a blood stem cell mutation that may lower Alzheimer’s risk. Learn how this breakthrough could shape ...

Break Through Cancer, a Boston-based cancer research foundation, has launched a clinical trial to evaluate the feasibility of ...

During a live event, Thomas LeBlanc, MD, MA, discussed dose escalation of luspatercept in myelodysplastic syndromes and ...

“Personalizing treatment in this way may lessen harmful side effects, reduce damage to healthy cells and make it more likely ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The Foundation also awarded Continuation Grants to three Damon Runyon Clinical Investigators, totaling $1,000,000 in additional funding. The Continuation Grants are designed to support Clinical ...

What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier ...

Haematopoiesis articles from across Nature Portfolio Atom RSS Feed Haematopoiesis refers to the commitment and differentiation processes that lead to the formation of all blood cells from ...

A new study indicates that a gene mutation could provide protection against Alzheimer's disease. The research focused on ...